Regulations.gov document
Guidance on Current Good Manufacturing Practice for Positron Emission Tomography Drugs…
Notice · FDA-1998-D-0025 · posted Dec 10, 2009
Key facts
| Document ID | FDA-1998-D-0025-0036 |
|---|---|
| Title | Guidance on Current Good Manufacturing Practice for Positron Emission Tomography Drugs; Availability |
| Document type | Notice |
| Subtype | NAD-Notice of Availability of Data |
| Agency | FDA |
| Docket | FDA-1998-D-0025 |
| Posted | Dec 10, 2009 |
| Federal Register citation | 74 FR 65538 |
| FR document number | E9-29286 |
| Comment period opens | Dec 10, 2009 |
| Effective date | Dec 10, 2009 |
At a glance
- 1–9 Pages
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: